A Cross-Sectional Study on the Identification of Risk Factors Associated with Stroke

Keerthi M; Anudeep V; Anusha Ch; Muntaz Ahmed MD

doi:10.37022/jcscr.v5i2.932

M. Keerthi Department of Pharmacy Practice, Avanthi Institute of Pharmaceutical Sciences Gunthapally, Hyderabad, Telangana, India.
V. Anudeep Department of Pharmacy Practice, Avanthi Institute of Pharmaceutical Sciences Gunthapally, Hyderabad, Telangana, India.
Ch. Anusha Department of Pharmacy Practice, Avanthi Institute of Pharmaceutical Sciences Gunthapally, Hyderabad, Telangana, India.
MD. Muntaz Ahmed Department of Pharmacy Practice, Avanthi Institute of Pharmaceutical Sciences Gunthapally, Hyderabad, Telangana, India.

DOI https://doi.org/10.37022/jcscr.v5i2.932

Abstract

Stroke is a major neurological disorder and one of the leading causes of morbidity and mortality worldwide. It occurs due to an interruption of blood supply to the brain, resulting in impaired neurological function. The present cross-sectional study was conducted to identify the major risk factors associated with stroke among patients admitted to the Department of Neurology. A total of 60 confirmed stroke patients, diagnosed through CT or MRI, were included in the study over a period of six months. Data were collected from both inpatient and outpatient departments and analyzed based on age, gender, risk factors, and types of stroke. The study revealed that stroke incidence was higher in males compared to females. A greater proportion of cases were observed in patients above 50 years of age, indicating advancing age as a significant risk factor. Hypertension, diabetes mellitus, dyslipidemia, smoking, alcohol consumption, and cardiovascular diseases were identified as the predominant risk factors. Ischemic stroke was found to be more common than hemorrhagic stroke. The analysis also showed that younger adults below 50 years were increasingly affected due to lifestyle modifications, sedentary habits, and early onset of vascular risk factors. Early identification and management of these modifiable risk factors may significantly reduce stroke occurrence and improve patient outcomes. The study emphasizes the importance of preventive strategies, awareness programs, and timely interventions to minimize the burden of stroke in the community.

Keywords: Stroke, Risk Factors, Hypertension, Diabetes Mellitus, Ischemic Stroke, Hemorrhagic Stroke, Cross-Sectional Study

References

1. World Health Organization. Global Health Estimates 2023. Geneva: WHO; 2023.
2. Feigin VL, Stark BA, Johnson CO, et al. Global burden of stroke and risk factors. Lancet Neurol. 2021;20(10):795-820.
3. American Stroke Association. Stroke facts and statistics. Stroke. 2023;54(3):e1-e10.
4. Campbell BCV, Khatri P. Stroke. N Engl J Med. 2020;382(8):757-771.
5. O’Donnell MJ, Chin SL, Rangarajan S, et al. Global and regional effects of potentially modifiable risk factors associated with acute stroke. Lancet. 2016;388(10046):761-775.
6. Pulusu VS, Chilamula S, Holkunde A, Gunturi R, Vidiyala P, Anekalla TR. Microplastics in the Environment: Sources, Detection Techniques, and Analytical Challenges. Open Access Libr. J. 2025;12:1-33.
7. Boehme AK, Esenwa C, Elkind MSV. Stroke risk factors, genetics, and prevention. Circ Res. 2017;120(3):472-495.
8. Lawes CMM, Vander Hoorn S, Rodgers A. Global burden of blood-pressure-related disease. Lancet. 2008;371(9623):1513-1518.
9. R. Prasad P. L., S. Govindaraj, P, Jahnavi, P. Popatrao Taru, T. Tummala, P. Vidiyala, N. Vidiyala, P. Balaji .Metal Oxide Functionalized Nanoparticles for the Treatment of Bacterial Infection: Synthesis,Characterization, and Therapeutic Applications. J. Appl. Organomet. Chem., 2025, 5(3), 232-257.
10. Katan M, Luft A. Global burden of stroke. Semin Neurol. 2018;38(2):208-211.
11. Donkor ES. Stroke in the 21st century: burden and prevention. BMC Public Health. 2018;18:1236.
12. Pulusu VS, Chilamula S, Holkunde A, Gunturi R, Vidiyala P, Bashetty SR. Microplastics and nanoplastics: Environmental pathways, ecological impacts, and regulatory perspectives. Open Access Library Journal. 2025;12(12):1-31.
13. Velmurugan R, Ravikumar L, Teriveedhi VK, Vidiyala P, Jahnavi P, Vodeti R, Elumalai S. Optimized Idronoxil-Loaded Polycaprolactone Nanoparticles for Targeted Liver Cancer Therapy: A Novel Approach in Drug Delivery Systems
14. Virani SS, Alonso A, Benjamin EJ, et al. Heart disease and stroke statistics—2023 update. Circulation. 2023;147:e93-e621.
15. Pandian JD, Sudhan P. Stroke epidemiology and stroke care services in India. J Stroke. 2013;15(3):128-134.
16. Benjamin EJ, Muntner P, Alonso A, Bittencourt MS, Callaway CW, Carson AP, et al. Heart disease and stroke statistics—2019 update. Circulation. 2019;139(10):e56-e528.
17. Powers WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bambakidis NC, Becker K, et al. Guidelines for the early management of acute ischemic stroke. Stroke. 2019;50(12):e344-e418.
18. Norrving B, Barrick J, Davalos A, Dichgans M, Cordonnier C, Guekht A, et al. Action plan for stroke in Europe 2018–2030. Eur Stroke J. 2018;3(4):309-336.
19. Virani SS, Alonso A, Aparicio HJ, Benjamin EJ, Bittencourt MS, Callaway CW, et al. Heart disease and stroke statistics—2021 update. Circulation. 2021;143(8):e254-e743.
20. Pandian JD, Gall SL, Kate MP, Silva GS, Akinyemi RO, Ovbiagele BI, et al. Prevention of stroke: a global perspective. Lancet. 2018;392(10154):1269-1278.